References
Tahara K, Mimori K, Iinuma H, et al. Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal Cancer. Ann Surg Oncol. 2010.
Jung K, Lein M, Laube C, Lichtinghagen R. Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood. Clin Chim Acta. 2001;314(1–2):241–4.
Green MJ, Gough AK, Devlin J, et al. Serum MMP-3 and MMP-1 and progression of joint damage in early rheumatoid arthritis. Rheumatology (Oxf). 2003;42(1):83–8.
Myers A, Lakey R, Cawston TE, et al. Serum MMP-1 and TIMP-1 levels are increased in patients with psoriatic arthritis and their siblings. Rheumatology (Oxf). 2004;43(3):272–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iwatsuki, M., Mimori, K., Tahara, K. et al. Reply: Preanalytical Interferences Compromise the Clinical Validity of Matrix Metalloproteinase 1 as Marker of Colorectal Cancer. Ann Surg Oncol 18 (Suppl 3), 233–234 (2011). https://doi.org/10.1245/s10434-010-1498-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-010-1498-x